SHAWNA BLOWE: Open Payments
NPI 1942407978 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,243 in 116 payments from 21 companies in 2025. Trend: 2023 $1,319 · 2024 $1,689 · 2025 $2,243
Food & beverage: $2,243
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 18 | $552 |
| ABBVIE INC. | 31 | $353 |
| Janssen Biotech, Inc. | 10 | $231 |
| Novartis Pharmaceuticals Corporation | 6 | $160 |
| PFIZER INC. | 19 | $159 |
| UCB, Inc. | 4 | $114 |
| AstraZeneca Pharmaceuticals LP | 4 | $101 |
| Mallinckrodt Hospital Products Inc. | 3 | $84 |
| GlaxoSmithKline, LLC. | 3 | $68 |
| E.R. Squibb & Sons, L.L.C. | 2 | $60 |
Products named: OTEZLA, TREMFYA, RINVOQ, EVENITY, SKYRIZI, XELJANZ, Bimzelx, SAPHNELO.
Industry payments across VA — which companies pay providers there.
